Елтромбопаг Сандоз

Eltrombopag Sandoz is an oral medication used to support blood platelet production. It belongs to the thrombopoietin receptor agonist class, prescribed for certain blood conditions. Suitable for adults and children with immune thrombocytopenia. Always consult a healthcare provider before use.

Eltrombopag is primarily used to increase platelet counts in people with immune thrombocytopenia (ITP), a condition where the immune system attacks platelets. It may also be prescribed for thrombocytopenia in chronic hepatitis C or severe aplastic anemia when standard treatments are insufficient. This medication helps reduce the risk of bleeding by supporting normal platelet function.

Eltrombopag works by stimulating the bone marrow to produce more platelets, which are essential for blood clotting. Users may notice improved ability to stop minor bleeding and reduced bruising over time. Effects vary by individual and may take several weeks to become noticeable. Regular blood tests are typically required to monitor platelet levels.

Store eltrombopag at room temperature away from moisture and heat. Keep out of reach of children and pets. Do not use if the packaging is damaged or the medication appears discolored. Inform your doctor about all current medications and medical conditions before starting treatment. Avoid taking with dairy products or calcium-rich foods within 2 hours of dosing.

Eltrombopag may interact with certain medications, including antacids, multivitamins, and supplements containing calcium, iron, magnesium, or zinc. These can reduce absorption; separate dosing by at least 2 hours. It may also interact with cholesterol-lowering drugs like statins and some HIV medications. Alcohol and grapefruit products may affect how the body processes eltrombopag.